Method for measuring the duration of inhibition of angiotensin I-converting enzyme in vivo
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Methods
- Vol. 5 (4), 305-312
- https://doi.org/10.1016/0160-5402(81)90042-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Plasma converting enzyme activity (C.E.A.) : An index of plasma levels of captopril?Life Sciences, 1980
- Contribution of the Kidneys but not Adrenal Glands to the Acute Antihypertensive Effects of Captopril in Spontaneously Hypertensive RatsClinical Science, 1979
- Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogsEuropean Journal of Pharmacology, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Fate of Angiotensin I in the CirculationNature, 1968